Tourette Syndrome Clinical Trial
Official title:
Online Mindfulness-based Tic Reduction: Development and Testing (Phase Two)
Verified date | April 2024 |
Source | Bowdoin College |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Tourette Syndrome (TS) and Persistent Tic Disorder (PTD) are chronic and potentially disabling neurobiological conditions. Although a range of pharmacological and psychosocial treatments exists, a significant number of individuals either do not respond to the current treatments or find them unacceptable. Thus, it is essential that researchers continue to develop and test novel treatment approaches. In this randomized controlled trial the investigators will compare two different online group-based interventions for tics: a mindfulness-based program (Mindfulness-based Intervention for Tics (MBIT), and a psychoeducational and supportive therapy program (Tic Information and Coping Strategies (TICS)). The purpose of this study is to determine which intervention is more helpful for adults with a tic disorder.
Status | Completed |
Enrollment | 37 |
Est. completion date | December 2, 2020 |
Est. primary completion date | December 2, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. be 18 years of age or older, 2. possess a primary diagnosis of Tourette Syndrome or Persistent Tic Disorder, 3. be fluent in English 4. reside in the United States, 5. either not be taking any tic suppressant medication or other psychotropic medication or be at a stable dose for 8 weeks prior to the baseline assessment and throughout the study Exclusion Criteria: 1. be receiving concurrent psychotherapy for the duration of the study 2. have prior extensive experience with mindfulness and/or meditation and 3. have another medical or psychological condition that would prevent the individual from fully engaging in the study or require a higher level of care (e.g., suicidality). |
Country | Name | City | State |
---|---|---|---|
United States | Massachusetts General Hospital | Boston | Massachusetts |
United States | Bowdoin College | Brunswick | Maine |
Lead Sponsor | Collaborator |
---|---|
Bowdoin College | Massachusetts General Hospital |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Yale Global Tic Severity Scale (YGTSS) Total Tic Severity Score | Clinician-rated measure of tic severity | Screening, Week 0, Week 9, Week 13, Week 35 | |
Secondary | Clinical Global Impressions Scale | Weeks 0, 9, 13, 35 | ||
Secondary | Adult Tic Questionnaire | Weeks 0, 9, 13, 35 | ||
Secondary | Yale-Brown Obsessive Compulsive Scale | Weeks 0, 9, 13, 35 | ||
Secondary | Attention-Deficit Hyperactivity Rating Scale | Weeks 0, 9, 13, 35 | ||
Secondary | Depression Anxiety Stress Scale | Weeks 0, 9, 13, 35 | ||
Secondary | Premonitory Urge to Tic Scale | Weeks 0, 9, 13, 35 | ||
Secondary | Tic Rating Form | Weeks 1-8 | ||
Secondary | Problem Rating Form | Weeks 1-8 | ||
Secondary | Patient Health Questionnaire-9 | Weeks 0, 9, 13, 35 | ||
Secondary | Work and Social Adjustment Survey | Weeks 0, 9, 13, 35 | ||
Secondary | Five Facet Mindfulness Questionnaire | Weeks 0, 4, 8, 9, 13, 35 | ||
Secondary | Credibility and Expectancy Questionnaire | Week 3 | ||
Secondary | Patient Satisfaction Questionnaire | Week 9 | ||
Secondary | Self Compassion Scale | Weeks 0, 9, 13, 35 | ||
Secondary | Affective Reactivity Index | Weeks 0, 9, 13, 35 | ||
Secondary | Brief Irritability Test | Weeks 0, 9, 13, 35 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04851678 -
Longitudinal Impact of Stressors in Adults With Tourette Syndrome
|
||
Completed |
NCT02605902 -
Trial to Demonstrate the Efficacy and Safety of Internet-delivered Behavioral Treatment for Adults With Tic Disorders
|
N/A | |
Completed |
NCT04007913 -
Incorporating teleCBIT Into a Hospital-Based Tic Program
|
N/A | |
Completed |
NCT02900144 -
Modified Comprehensive Behavioral Intervention for Tics (M_CBIT)
|
N/A | |
Completed |
NCT02216474 -
Brain Stimulation in Movement Disorders
|
N/A | |
Completed |
NCT02256475 -
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
|
Phase 1 | |
Completed |
NCT01329198 -
Brain Stimulation for the Treatment of Tourette Syndrome
|
N/A | |
Terminated |
NCT00952601 -
Pilot Study of the Modified Atkins Diet for Tourette Syndrome
|
Phase 1 | |
Enrolling by invitation |
NCT00355927 -
Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
|
N/A | |
Completed |
NCT00206323 -
A Randomized, Placebo-controlled, Tourette Syndrome Study.
|
Phase 3 | |
Completed |
NCT00004376 -
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder
|
Phase 3 | |
Completed |
NCT04498364 -
Extinction Learning in Adults With Tourette Syndrome
|
N/A | |
Completed |
NCT00755339 -
Role of the Sensory Experience in Generating Motor Tics in Tourette Syndrome
|
||
Completed |
NCT03325010 -
Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT06081348 -
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
|
Phase 2 | |
Completed |
NCT01719523 -
Open-Trial of EPI-743 for Adults With Tourette Syndrome
|
Phase 1 | |
Completed |
NCT01702077 -
Neurofeedback for Tourette Syndrome
|
N/A | |
Completed |
NCT00231985 -
Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder
|
Phase 2 | |
Completed |
NCT00206336 -
An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.
|
Phase 3 | |
Terminated |
NCT03732534 -
Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome
|
Phase 2 |